EGFR and glioma: EGFR amplification is often associated with high expression of EGFRvIII, a ligand-independent constitutively active mutant of EGFR, capable of persistently activating PI3K/v-Akt murine thymoma viral oncogene homolog (Akt) signaling pathway that promotes the survival of the glioma cells.